RA Capital Management’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184M | Hold |
10,138,938
| – | – | 3.09% | 9 |
|
|
2025
Q1 | $208M | Buy |
10,138,938
+1,293,938
| +15% | +$26.5M | 3.47% | 5 |
|
|
2024
Q4 | $227M | Buy |
8,845,000
+781,000
| +10% | +$20.1M | 3.03% | 7 |
|
|
2024
Q3 | $134M | Hold |
8,064,000
| – | – | 1.54% | 21 |
|
|
2024
Q2 | $155M | Buy |
8,064,000
+200,000
| +3% | +$3.84M | 2.05% | 16 |
|
|
2024
Q1 | $186M | Hold |
7,864,000
| – | – | 2.37% | 8 |
|
|
2023
Q4 | $87.8M | Sell |
7,864,000
-1,136,000
| -13% | -$12.7M | 1.37% | 21 |
|
|
2023
Q3 | $83.3M | Hold |
9,000,000
| – | – | 1.64% | 19 |
|
|
2023
Q2 | $107M | Buy |
9,000,000
+5,000,000
| +125% | +$59.5M | 2.02% | 11 |
|
|
2023
Q1 | $53M | Hold |
4,000,000
| – | – | 1.2% | 27 |
|
|
2022
Q4 | $43.6M | Buy |
+4,000,000
| New | +$43.6M | 0.88% | 35 |
|